|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
11 December 2023 |
|
Main ID: |
NCT04016168 |
|
Date of registration:
|
08/07/2019 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Idiopathic Pulmonary Fibrosis and Serum Bank
FPI |
|
Scientific title:
|
Idiopathic Pulmonary Fibrosis and Serum Bank |
|
Date of first enrolment:
|
October 22, 2014 |
|
Target sample size:
|
903 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/ct2/show/NCT04016168 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Stéphane JOUNEAU, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Hospital of Rennes |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients seen on an outpatient basis and in stable or acute condition
- Patient over 18 years of age.
- The inclusion criteria will be those edited by the American Thoracic Society (ATS) and
the European Respiratory Society (ERS) to diagnosis IPF
Exclusion Criteria:
- Patients who are unable or unwilling to sign the consent.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Idiopathic Pulmonary Fibrosis
|
|
Lung Diseases, Interstitial
|
|
Intervention(s)
|
|
Biological: Blood sample collection
|
|
Primary Outcome(s)
|
|
Determination of circulating CD163 serum concentration
[Time Frame: Through study completion, an average of 4 years]
|
|
Secondary ID(s)
|
|
2014-A00268-39
|
|
35RC14_9722
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|